Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBGMS vs Medication in Type 2 Diabetes
NCT02185755Completed
- Sponsor
- Endocrine Research Society
- Start
- Aug 2014
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Endocrine Research Society. Primary endpoint: HbA1c Levels at 6 months. Started Aug 2014; status: completed.
Beyond the preview
Go deeper on NCT02185755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185755.